Loading…
Based on limited metadata, Pure Source LLC received an FDA Warning Letter on February 20, 2019, regarding a product categorized as "Other," though specific product details are not available. Without access to the full warning letter text or a documented subject line, the precise nature of the violations cannot be determined from this metadata alone. The issuing office information is similarly unavailable, limiting insight into which FDA division or field office initiated the enforcement action. To understand the specific regulatory concerns and compliance requirements, access to the complete warning letter would be necessary.